Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
19 studies found for:    "Benign Breast Disease"
Show Display Options
Rank Status Study
1 Completed Effects of Tamoxifen in Women With Benign Breast Disease Not Having Any Risks of Developing Breast Cancer
Conditions: Benign Breast Disease;   Fibrocystic Disease of Breast;   Fibroadenoma;   Mastalgia
Interventions: Drug: Tamoxifen;   Drug: Evening Primrose Oil
2 Unknown  Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain
Conditions: Fibrocystic Disease of Breast;   Fibrocystic Changes of Breast;   Fibrocystic Mastopathy;   Pain
Intervention: Drug: IoGen (molecular iodine)
3 Completed A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease
Condition: Fibrocystic Disease of Breast
Interventions: Drug: danazol;   Drug: Placebo
4 Completed Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease
Condition: Breast Fibrocystic Disease
Interventions: Dietary Supplement: Oncoxin;   Dietary Supplement: Placebo
5 Unknown  China CellSearch Study
Conditions: Metastatic Breast Cancer;   Benign Breast Disease
Intervention:
6 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
7 Active, not recruiting Genetics of Mammographic Appearances and Patterns (The GenMap Study)
Condition: Benign Breast Disease
Intervention:
8 Completed Prolactin Receptor and Breast Diseases
Conditions: Benign Breast Disease;   Breast Cancer
Interventions: Biological: blood collection for hormonal status analysis;   Procedure: breast Biopsy or surgery;   Genetic: blood collection;   Other: ultrasonography (pelvis and breast), bone mineral density
9 Completed Nuclear Morphology of Breast Cells in Ductal Lavage
Condition: Benign Breast Disease
Intervention: Procedure: breast ductal lavage
10 Enrolling by invitation VITamin D and OmegA-3 TriaL: Effects on Mammographic Density and Breast Tissue
Condition: Benign Breast Disease
Interventions: Dietary Supplement: Vitamin D and fish oil placebo;   Dietary Supplement: Fish oil and vitamin D placebo;   Dietary Supplement: Vitamin D placebo and fish oil placebo;   Dietary Supplement: Vitamin D and fish oil
11 Recruiting Johns Hopkins Breast Cancer Program Longitudinal Repository
Conditions: Breast Cancer;   Benign Breast Disease
Intervention: Procedure: Sample collection
12 Enrolling by invitation A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses
Conditions: Fibrocystic Disease of Breast;   Breast Cancer
Intervention: Device: Digital Breast Tomosynthesis
13 Withdrawn Involvement of Endogenous Digitalis-like Compounds in Breast Cancer
Conditions: Breast Neoplasms;   Fibrocystic Disease of Breast;   Mammaplasty
Intervention:
14 Active, not recruiting Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
Condition: Breast Cancer
Interventions: Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: proteomic profiling;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: fluorescent antibody technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: liquid chromatography;   Other: mass spectrometry;   Other: medical chart review;   Procedure: quality-of-life assessment
15 Terminated Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
Condition: Breast Cancer
Interventions: Genetic: protein analysis;   Genetic: protein expression analysis;   Genetic: proteomic profiling;   Other: diagnostic laboratory biomarker analysis;   Other: immunohistochemistry staining method;   Other: liquid chromatography;   Other: mass spectrometry;   Procedure: fine-needle aspiration;   Procedure: needle biopsy;   Procedure: radiomammography
16 Recruiting Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Conditions: Ductal Breast Carcinoma In Situ;   Lobular Breast Carcinoma In Situ;   Paget Disease of the Breast;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Docosahexaenoic Acid;   Other: Placebo;   Other: Laboratory Biomarker Analysis
17 Completed
Has Results
Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation
Condition: Breast Cancer
Intervention: Device: Molecular Breast Imaging
18 Unknown  Women At Risk: The High Risk Breast Cancer Program
Condition: Breast Cancer
Intervention:
19 Completed An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia
Condition: Moderate to Severe Cyclic Mastalgia
Intervention: Drug: Danazol

Indicates status has not been verified in more than two years